Nathan Novotny
Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 10 | 2025 | 466 | 3.930 |
Why?
| | Appendicitis | 5 | 2021 | 130 | 1.820 |
Why?
| | Appendectomy | 5 | 2020 | 79 | 1.720 |
Why?
| | Hernia, Inguinal | 4 | 2023 | 36 | 1.690 |
Why?
| | Herniorrhaphy | 5 | 2024 | 60 | 1.650 |
Why?
| | Pyloric Stenosis, Hypertrophic | 3 | 2024 | 10 | 1.520 |
Why?
| | Pyloromyotomy | 2 | 2024 | 2 | 1.440 |
Why?
| | Foreign Bodies | 4 | 2022 | 104 | 1.370 |
Why?
| | Disposable Equipment | 2 | 2020 | 19 | 1.220 |
Why?
| | Surgical Instruments | 2 | 2020 | 51 | 1.190 |
Why?
| | Duodenal Obstruction | 1 | 2025 | 5 | 0.970 |
Why?
| | Anastomosis, Surgical | 2 | 2025 | 153 | 0.960 |
Why?
| | Surgical Stapling | 1 | 2025 | 15 | 0.960 |
Why?
| | Wounds, Nonpenetrating | 3 | 2023 | 278 | 0.950 |
Why?
| | Duodenum | 1 | 2025 | 78 | 0.930 |
Why?
| | Magnets | 3 | 2022 | 19 | 0.930 |
Why?
| | Retrospective Studies | 29 | 2025 | 15657 | 0.900 |
Why?
| | Abdominal Injuries | 2 | 2023 | 123 | 0.900 |
Why?
| | Suture Techniques | 1 | 2025 | 122 | 0.890 |
Why?
| | Hernia, Femoral | 1 | 2024 | 4 | 0.880 |
Why?
| | Tracheoesophageal Fistula | 2 | 2022 | 33 | 0.830 |
Why?
| | Peritoneum | 2 | 2023 | 44 | 0.740 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2022 | 59 | 0.730 |
Why?
| | Colitis, Ulcerative | 1 | 2023 | 136 | 0.720 |
Why?
| | Gastroschisis | 1 | 2021 | 29 | 0.700 |
Why?
| | Digestive System Surgical Procedures | 1 | 2022 | 106 | 0.700 |
Why?
| | Child | 28 | 2024 | 21935 | 0.700 |
Why?
| | Bronchoscopy | 2 | 2018 | 223 | 0.660 |
Why?
| | Operative Time | 4 | 2025 | 145 | 0.650 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 60 | 0.650 |
Why?
| | Thoracoscopy | 1 | 2020 | 56 | 0.640 |
Why?
| | Bronchi | 2 | 2018 | 260 | 0.640 |
Why?
| | Biological Products | 1 | 2023 | 216 | 0.630 |
Why?
| | Caustics | 1 | 2019 | 7 | 0.620 |
Why?
| | Accidents, Home | 1 | 2019 | 31 | 0.610 |
Why?
| | Esophageal Diseases | 1 | 2019 | 28 | 0.610 |
Why?
| | Burns, Chemical | 1 | 2019 | 32 | 0.600 |
Why?
| | Adjuvants, Anesthesia | 1 | 2018 | 12 | 0.600 |
Why?
| | Patient Satisfaction | 2 | 2020 | 660 | 0.600 |
Why?
| | Developing Countries | 4 | 2024 | 307 | 0.600 |
Why?
| | Midazolam | 1 | 2018 | 56 | 0.580 |
Why?
| | Postoperative Care | 1 | 2020 | 261 | 0.580 |
Why?
| | Tracheal Neoplasms | 1 | 2017 | 9 | 0.570 |
Why?
| | Needles | 1 | 2018 | 59 | 0.570 |
Why?
| | Neurilemmoma | 1 | 2017 | 24 | 0.560 |
Why?
| | Gastrostomy | 2 | 2009 | 117 | 0.550 |
Why?
| | Metals, Rare Earth | 1 | 2017 | 3 | 0.550 |
Why?
| | Child, Preschool | 15 | 2024 | 11074 | 0.540 |
Why?
| | Cautery | 1 | 2017 | 4 | 0.540 |
Why?
| | Inguinal Canal | 1 | 2017 | 10 | 0.540 |
Why?
| | Surgical Procedures, Operative | 1 | 2020 | 259 | 0.540 |
Why?
| | Infant | 12 | 2025 | 9465 | 0.540 |
Why?
| | Humans | 57 | 2025 | 137585 | 0.530 |
Why?
| | Rare Diseases | 1 | 2017 | 104 | 0.530 |
Why?
| | Esophagus | 1 | 2019 | 255 | 0.520 |
Why?
| | Postoperative Complications | 4 | 2025 | 2654 | 0.500 |
Why?
| | Trachea | 1 | 2017 | 237 | 0.490 |
Why?
| | Abdomen | 2 | 2023 | 125 | 0.490 |
Why?
| | Global Health | 1 | 2019 | 386 | 0.490 |
Why?
| | Anesthesia | 1 | 2018 | 189 | 0.480 |
Why?
| | Treatment Outcome | 12 | 2025 | 10811 | 0.460 |
Why?
| | Female | 33 | 2025 | 73304 | 0.430 |
Why?
| | Catheters, Indwelling | 2 | 2011 | 91 | 0.410 |
Why?
| | Patient-Centered Care | 1 | 2018 | 530 | 0.410 |
Why?
| | Stem Cell Transplantation | 3 | 2008 | 176 | 0.400 |
Why?
| | Sepsis | 2 | 2009 | 617 | 0.390 |
Why?
| | Length of Stay | 5 | 2025 | 1215 | 0.370 |
Why?
| | Male | 27 | 2025 | 67762 | 0.370 |
Why?
| | Robotics | 2 | 2023 | 94 | 0.370 |
Why?
| | Recurrence | 4 | 2023 | 1060 | 0.360 |
Why?
| | Omentum | 1 | 2011 | 10 | 0.360 |
Why?
| | Robotic Surgical Procedures | 2 | 2023 | 130 | 0.350 |
Why?
| | Neutropenia | 1 | 2011 | 146 | 0.340 |
Why?
| | Rectus Abdominis | 1 | 2009 | 17 | 0.320 |
Why?
| | Peritoneal Dialysis | 1 | 2011 | 97 | 0.310 |
Why?
| | Longevity | 1 | 2011 | 165 | 0.310 |
Why?
| | Infant, Newborn | 6 | 2025 | 6079 | 0.310 |
Why?
| | Compartment Syndromes | 1 | 2009 | 25 | 0.310 |
Why?
| | Angiopoietin-1 | 1 | 2009 | 11 | 0.310 |
Why?
| | Fissure in Ano | 1 | 2008 | 4 | 0.300 |
Why?
| | Barium Radioisotopes | 1 | 2008 | 2 | 0.300 |
Why?
| | Barium | 1 | 2008 | 26 | 0.300 |
Why?
| | Estrogens | 2 | 2008 | 367 | 0.300 |
Why?
| | Fundoplication | 1 | 2009 | 53 | 0.300 |
Why?
| | Peptic Ulcer | 1 | 2008 | 20 | 0.290 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2008 | 79 | 0.290 |
Why?
| | Adolescent | 12 | 2023 | 21513 | 0.280 |
Why?
| | Intestinal Volvulus | 1 | 2007 | 22 | 0.270 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2008 | 140 | 0.270 |
Why?
| | Vascular Endothelial Growth Factor A | 5 | 2009 | 545 | 0.260 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2009 | 323 | 0.260 |
Why?
| | Neuroblastoma | 1 | 2008 | 160 | 0.260 |
Why?
| | Injury Severity Score | 3 | 2023 | 522 | 0.260 |
Why?
| | Gastroesophageal Reflux | 1 | 2009 | 234 | 0.250 |
Why?
| | Gastric Bypass | 1 | 2007 | 119 | 0.250 |
Why?
| | Duodenostomy | 1 | 2025 | 5 | 0.240 |
Why?
| | Ischemia | 1 | 2009 | 409 | 0.240 |
Why?
| | Intestinal Atresia | 1 | 2025 | 15 | 0.240 |
Why?
| | DNA Damage | 1 | 2008 | 420 | 0.230 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 622 | 0.230 |
Why?
| | Interleukin-6 | 2 | 2008 | 778 | 0.230 |
Why?
| | NF-kappa B | 1 | 2008 | 691 | 0.220 |
Why?
| | Spleen | 2 | 2023 | 514 | 0.220 |
Why?
| | Intestinal Obstruction | 1 | 2024 | 51 | 0.210 |
Why?
| | Obesity, Morbid | 1 | 2007 | 264 | 0.210 |
Why?
| | Mediastinal Emphysema | 1 | 2023 | 7 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2024 | 119 | 0.200 |
Why?
| | Esophageal Perforation | 1 | 2023 | 15 | 0.200 |
Why?
| | Intestine, Small | 1 | 2024 | 156 | 0.200 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 508 | 0.200 |
Why?
| | Biological Factors | 1 | 2023 | 39 | 0.200 |
Why?
| | Follow-Up Studies | 4 | 2023 | 5131 | 0.200 |
Why?
| | Splenic Artery | 1 | 2022 | 14 | 0.200 |
Why?
| | Morbidity | 2 | 2022 | 324 | 0.200 |
Why?
| | Lacerations | 1 | 2023 | 35 | 0.200 |
Why?
| | Esophagoplasty | 1 | 2022 | 2 | 0.200 |
Why?
| | Infliximab | 1 | 2023 | 111 | 0.190 |
Why?
| | Internship and Residency | 2 | 2023 | 1147 | 0.190 |
Why?
| | Silicones | 1 | 2022 | 25 | 0.190 |
Why?
| | Remission Induction | 1 | 2023 | 288 | 0.190 |
Why?
| | Esophageal Atresia | 1 | 2022 | 26 | 0.190 |
Why?
| | Aging | 3 | 2008 | 1864 | 0.180 |
Why?
| | Prognosis | 2 | 2021 | 4030 | 0.180 |
Why?
| | Spectrometry, Fluorescence | 1 | 2022 | 168 | 0.180 |
Why?
| | General Surgery | 1 | 2023 | 173 | 0.180 |
Why?
| | Contrast Media | 1 | 2024 | 467 | 0.180 |
Why?
| | Radiation Exposure | 1 | 2021 | 49 | 0.180 |
Why?
| | Oxidative Stress | 1 | 2008 | 1317 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2024 | 307 | 0.180 |
Why?
| | Myocardial Infarction | 1 | 2008 | 1046 | 0.170 |
Why?
| | Middle East | 1 | 2020 | 15 | 0.170 |
Why?
| | Simulation Training | 1 | 2022 | 106 | 0.170 |
Why?
| | Clostridium Infections | 1 | 2021 | 73 | 0.170 |
Why?
| | Time | 1 | 2020 | 83 | 0.160 |
Why?
| | Radiography | 3 | 2019 | 822 | 0.150 |
Why?
| | Developed Countries | 1 | 2019 | 39 | 0.150 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 43 | 0.150 |
Why?
| | Spinal Injuries | 1 | 2019 | 53 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 1 | 2021 | 285 | 0.150 |
Why?
| | Transforming Growth Factor alpha | 2 | 2009 | 57 | 0.150 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2009 | 134 | 0.150 |
Why?
| | Laryngeal Masks | 1 | 2018 | 14 | 0.150 |
Why?
| | Cross Infection | 1 | 2021 | 256 | 0.150 |
Why?
| | Deep Sedation | 1 | 2018 | 14 | 0.150 |
Why?
| | Critical Pathways | 1 | 2019 | 96 | 0.140 |
Why?
| | Cervical Vertebrae | 1 | 2019 | 137 | 0.140 |
Why?
| | Age Distribution | 1 | 2019 | 392 | 0.140 |
Why?
| | Thoracotomy | 1 | 2018 | 75 | 0.140 |
Why?
| | Pylorus | 1 | 2017 | 18 | 0.140 |
Why?
| | Stents | 1 | 2022 | 527 | 0.140 |
Why?
| | Intestines | 1 | 2021 | 357 | 0.140 |
Why?
| | Adult | 9 | 2023 | 37929 | 0.140 |
Why?
| | Fluoroscopy | 1 | 2018 | 154 | 0.140 |
Why?
| | Electrocoagulation | 1 | 2017 | 40 | 0.140 |
Why?
| | Umbilicus | 1 | 2017 | 18 | 0.140 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 431 | 0.140 |
Why?
| | Cost Savings | 1 | 2017 | 84 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 591 | 0.140 |
Why?
| | Interviews as Topic | 1 | 2020 | 786 | 0.130 |
Why?
| | Delayed Diagnosis | 1 | 2017 | 91 | 0.130 |
Why?
| | Lipopolysaccharides | 3 | 2009 | 886 | 0.130 |
Why?
| | Cicatrix | 1 | 2017 | 64 | 0.130 |
Why?
| | Positron-Emission Tomography | 1 | 2017 | 294 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2023 | 758 | 0.120 |
Why?
| | Airway Obstruction | 1 | 2017 | 162 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2691 | 0.110 |
Why?
| | Liver | 1 | 2023 | 1943 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1809 | 0.110 |
Why?
| | Family | 1 | 2018 | 671 | 0.110 |
Why?
| | Hospitalization | 1 | 2024 | 2199 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1483 | 0.100 |
Why?
| | Surgeons | 1 | 2017 | 297 | 0.100 |
Why?
| | Animals | 11 | 2009 | 36940 | 0.100 |
Why?
| | Healthcare Disparities | 1 | 2019 | 654 | 0.100 |
Why?
| | Risk Factors | 3 | 2024 | 10388 | 0.100 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 2 | 2009 | 87 | 0.090 |
Why?
| | Paracrine Communication | 2 | 2008 | 65 | 0.090 |
Why?
| | Animals, Newborn | 3 | 2008 | 844 | 0.090 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2008 | 52 | 0.090 |
Why?
| | Disease Models, Animal | 4 | 2008 | 4295 | 0.090 |
Why?
| | Stomach Diseases | 1 | 2010 | 20 | 0.090 |
Why?
| | Jejunum | 1 | 2010 | 31 | 0.090 |
Why?
| | Equipment Failure | 1 | 2011 | 108 | 0.090 |
Why?
| | Cytokines | 2 | 2009 | 2085 | 0.080 |
Why?
| | Attitude of Health Personnel | 1 | 2018 | 1171 | 0.080 |
Why?
| | Stomach | 1 | 2010 | 110 | 0.080 |
Why?
| | Mice | 6 | 2009 | 17787 | 0.080 |
Why?
| | Hypertension | 2 | 2009 | 1295 | 0.080 |
Why?
| | Receptor Cross-Talk | 1 | 2009 | 21 | 0.080 |
Why?
| | Gastroscopy | 1 | 2009 | 19 | 0.080 |
Why?
| | Laparotomy | 1 | 2009 | 109 | 0.080 |
Why?
| | Infusions, Intra-Arterial | 1 | 2008 | 59 | 0.080 |
Why?
| | Cells, Cultured | 4 | 2009 | 4193 | 0.080 |
Why?
| | Pancreatic Elastase | 1 | 2008 | 58 | 0.070 |
Why?
| | Tumor Necrosis Factors | 1 | 2008 | 11 | 0.070 |
Why?
| | Aorta, Abdominal | 1 | 2008 | 46 | 0.070 |
Why?
| | Trauma Centers | 2 | 2023 | 421 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 889 | 0.070 |
Why?
| | Pressure | 1 | 2009 | 225 | 0.070 |
Why?
| | Orchiectomy | 1 | 2008 | 71 | 0.070 |
Why?
| | Young Adult | 3 | 2023 | 13209 | 0.070 |
Why?
| | Propanolamines | 1 | 2009 | 96 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2008 | 22 | 0.070 |
Why?
| | Adult Stem Cells | 1 | 2008 | 40 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2008 | 55 | 0.070 |
Why?
| | Comet Assay | 1 | 2008 | 16 | 0.070 |
Why?
| | Electrophoresis | 1 | 2008 | 32 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 6763 | 0.070 |
Why?
| | Endotoxins | 1 | 2009 | 220 | 0.070 |
Why?
| | Rats | 4 | 2008 | 5647 | 0.070 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 179 | 0.070 |
Why?
| | Anus, Imperforate | 1 | 2007 | 24 | 0.070 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2008 | 135 | 0.070 |
Why?
| | Chi-Square Distribution | 1 | 2009 | 530 | 0.070 |
Why?
| | Enema | 1 | 2007 | 47 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 257 | 0.070 |
Why?
| | Steroids | 1 | 2008 | 167 | 0.070 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5778 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 384 | 0.070 |
Why?
| | Middle Aged | 2 | 2020 | 33479 | 0.070 |
Why?
| | Random Allocation | 1 | 2008 | 353 | 0.070 |
Why?
| | Stem Cells | 2 | 2008 | 594 | 0.070 |
Why?
| | Models, Biological | 3 | 2009 | 1783 | 0.070 |
Why?
| | Probability | 1 | 2008 | 304 | 0.070 |
Why?
| | Enteral Nutrition | 1 | 2009 | 202 | 0.070 |
Why?
| | Gonadal Steroid Hormones | 1 | 2008 | 140 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2008 | 313 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 286 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2008 | 286 | 0.070 |
Why?
| | Fecal Incontinence | 1 | 2007 | 86 | 0.060 |
Why?
| | Administration, Oral | 1 | 2009 | 816 | 0.060 |
Why?
| | Gastrointestinal Diseases | 1 | 2008 | 209 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 366 | 0.060 |
Why?
| | Reference Values | 1 | 2008 | 816 | 0.060 |
Why?
| | Mice, Nude | 1 | 2008 | 698 | 0.060 |
Why?
| | Incidence | 2 | 2024 | 2804 | 0.060 |
Why?
| | Ventricular Remodeling | 1 | 2008 | 266 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 385 | 0.060 |
Why?
| | Mice, Inbred C57BL | 4 | 2008 | 5757 | 0.060 |
Why?
| | Reperfusion Injury | 1 | 2008 | 279 | 0.060 |
Why?
| | Kidney Failure, Chronic | 1 | 2011 | 570 | 0.060 |
Why?
| | Clinical Competence | 2 | 2023 | 1118 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2009 | 3015 | 0.060 |
Why?
| | Testosterone | 1 | 2008 | 409 | 0.060 |
Why?
| | Estradiol | 1 | 2008 | 521 | 0.060 |
Why?
| | Cardiac Catheterization | 1 | 2008 | 530 | 0.060 |
Why?
| | Tissue Adhesions | 1 | 2024 | 32 | 0.060 |
Why?
| | Heart | 1 | 2008 | 655 | 0.050 |
Why?
| | Hemodynamics | 1 | 2009 | 1113 | 0.050 |
Why?
| | Glucose | 1 | 2009 | 1020 | 0.050 |
Why?
| | Myocardium | 1 | 2009 | 1002 | 0.050 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2031 | 0.050 |
Why?
| | Splenomegaly | 1 | 2022 | 15 | 0.050 |
Why?
| | Morals | 1 | 2024 | 82 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1946 | 0.050 |
Why?
| | Play and Playthings | 1 | 2022 | 33 | 0.050 |
Why?
| | Splenectomy | 1 | 2022 | 62 | 0.050 |
Why?
| | Needs Assessment | 1 | 2023 | 376 | 0.040 |
Why?
| | Gestational Age | 1 | 2024 | 910 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2022 | 179 | 0.040 |
Why?
| | Ligation | 1 | 2020 | 92 | 0.040 |
Why?
| | United States | 3 | 2022 | 14841 | 0.040 |
Why?
| | Poverty | 1 | 2024 | 521 | 0.040 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2022 | 228 | 0.040 |
Why?
| | Michigan | 1 | 2019 | 109 | 0.040 |
Why?
| | Eating | 1 | 2022 | 380 | 0.040 |
Why?
| | Education, Medical, Graduate | 1 | 2023 | 486 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1007 | 0.040 |
Why?
| | Signal Transduction | 2 | 2008 | 5079 | 0.040 |
Why?
| | Computer Simulation | 1 | 2022 | 978 | 0.030 |
Why?
| | Inflammation | 1 | 2009 | 2837 | 0.030 |
Why?
| | Hypertension, Pulmonary | 1 | 2008 | 1910 | 0.030 |
Why?
| | Curriculum | 1 | 2023 | 992 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2024 | 951 | 0.030 |
Why?
| | Transfection | 2 | 2009 | 945 | 0.030 |
Why?
| | RNA, Small Interfering | 2 | 2009 | 622 | 0.030 |
Why?
| | Quality of Life | 1 | 2007 | 2892 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 691 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1357 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2023 | 3556 | 0.030 |
Why?
| | Program Evaluation | 1 | 2019 | 898 | 0.030 |
Why?
| | Heart Failure | 1 | 2008 | 2236 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2019 | 786 | 0.030 |
Why?
| | Time Factors | 1 | 2024 | 6828 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2008 | 1242 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2828 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 2 | 2008 | 2486 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1704 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5742 | 0.020 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2010 | 28 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3457 | 0.020 |
Why?
| | Short Bowel Syndrome | 1 | 2008 | 26 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2008 | 48 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 38 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 162 | 0.020 |
Why?
| | Organ Specificity | 1 | 2008 | 305 | 0.020 |
Why?
| | Stromal Cells | 1 | 2008 | 112 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 70 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 165 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 171 | 0.020 |
Why?
| | Osteoblasts | 1 | 2008 | 126 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 7604 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2008 | 341 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2008 | 202 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 350 | 0.020 |
Why?
| | RNA Interference | 1 | 2008 | 469 | 0.020 |
Why?
| | Tibia | 1 | 2008 | 178 | 0.020 |
Why?
| | Adipocytes | 1 | 2008 | 222 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 2008 | 263 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2008 | 1092 | 0.020 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 319 | 0.020 |
Why?
| | Femur | 1 | 2008 | 254 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 840 | 0.010 |
Why?
| | Tissue Engineering | 1 | 2008 | 423 | 0.010 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2008 | 351 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1759 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 526 | 0.010 |
Why?
| | Fibroblasts | 1 | 2008 | 996 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2008 | 785 | 0.010 |
Why?
| | Sex Factors | 1 | 2008 | 2071 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 916 | 0.010 |
Why?
| | Age Factors | 1 | 2008 | 3295 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1590 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2553 | 0.010 |
Why?
|
|
Novotny's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|